August 1st 2023Expansive growth in the gene and cell therapy (GCT) space has led to developers and manufacturers facing a multitude of challenges on the road to commercialization. To overcome issues associated with navigating a dynamic regulatory landscape and accessing adequate capacity to meet growing demand, GCT producers must employ the right process and analytical development approaches.
In this article, GCT experts at Pfizer CentreOne outline the intricate needs encountered throughout process and analytical development and explore the strategies Pfizer CentreOne employs to help its customers overcome development bottlenecks and troubleshoot fast.
